The Pistoia Alliance Quantum Computing Community of Interest is dedicated to investigating the rapidly evolving field of quantum computing and its transformative potential in the pharmaceutical sector. Though quantum computing is still in its early stages, the impact it could have on pharma research and development is enormous. As quantum technology matures, its ability to drive significant advancements in drug discovery and development will grow.
In today’s environment, the focus on AI, machine learning, and generative AI often overshadows the progress in quantum computing. This raises important questions: Does the rise of large language models (LLMs) lessen the benefits of quantum computing in pharma? Can certain tasks originally intended for quantum computing be handled by LLMs? How can the pharmaceutical industry effectively integrate quantum computing into its R&D efforts? And does the industry possess the skills needed to fully harness quantum technology?
To address these critical questions, the Pistoia Alliance is hosting a series of three webinars under the theme: “Quantum Computing in Life Science R&D: Where Are We, Where Are We Going, When Will We Get There?”
Webinar #2: “Where Are We Going?”
Sonali Mohapatra
Quantum Innovation Sector Lead, NQCC
16:25: Non-Commercial R&D Perspective